Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Phibro Animal Health (PAHC) Short-Term Debt issuances (2018 - 2022)

Phibro Animal Health has reported Short-Term Debt issuances over the past 5 years, most recently at -$1.9 million for Q1 2022.

  • For Q1 2022, Short-Term Debt issuances rose 60.0% year-over-year to -$1.9 million; the TTM value through Mar 2022 reached -$212.2 million, down 1132.0%, while the annual FY2021 figure was -$220.6 million, 1644.62% down from the prior year.
  • Short-Term Debt issuances for Q1 2022 was -$1.9 million at Phibro Animal Health, roughly flat from -$1.9 million in the prior quarter.
  • Over five years, Short-Term Debt issuances peaked at -$1.9 million in Q3 2021 and troughed at -$206.6 million in Q2 2021.
  • A 5-year average of -$16.8 million and a median of -$3.1 million in 2019 define the central range for Short-Term Debt issuances.
  • On a YoY basis, Short-Term Debt issuances climbed as much as 60.0% in 2021 and fell as far as 6436.77% in 2021.
  • Year by year, Short-Term Debt issuances stood at -$3.1 million in 2018, then fell by 0.06% to -$3.1 million in 2019, then crashed by 48.98% to -$4.7 million in 2020, then surged by 60.0% to -$1.9 million in 2021, then changed by 0.0% to -$1.9 million in 2022.
  • Business Quant data shows Short-Term Debt issuances for PAHC at -$1.9 million in Q1 2022, -$1.9 million in Q4 2021, and -$1.9 million in Q3 2021.